1. AF.124 EFFECTIVENESS AND SAFETY OF 1L PEG-ASC PREPARATION FOR COLONOSCOPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES. (September 2021) Authors: Maida, M.; Morreale, G.C.; Sferrazza, S.; Sinagra, E.; Scalisi, G.; Vitello, A.; Vettori, G.; Rossi, F.; Catarella, D.; Di Bartolo, C.E.; Schillaci, D.; Camilleri, S.; Orlando, A.; Macaluso, F.S. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S194 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AF.51 VEDOLIZUMAB MAY BE AN EFFECTIVE OPTION FOR THE MANAGEMENT OF POSTOPERATIVE RECURRENCE OF CROHN'S DISEASE. (September 2021) Authors: Macaluso, F.S.; Cappello, M.; Crispino, F.; Grova, M.; Privitera, A.C.; Piccillo, G.; Magnano, A.; Ferracane, C.; Belluardo, N.; Giangreco, E.; Fries, W.; Viola, A.; Di Mitri, R.; Mocciaro, F.; Camilleri, S.; Garufi, S.; Renna, S.; Casà, A.; Maida, M.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AF.57 SPOSAB ABP 501: A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501. (September 2021) Authors: Macaluso, F.S.; Cappello, M.; Busacca, A.; Fries, W.; Viola, A.; Costantino, G.; Magnano, A.; Vinci, E.; Ferracane, C.; Privitera, A.C.; Piccillo, G.; Belluardo, N.; Giangreco, E.; Romano, C.; Citrano, M.; Graziano, F.; Garufi, S.; Bertolami, C.; Ventimiglia, M.; Scrivo, B. Journal: Digestive and liver disease Issue: Volume 53(2021)Supplement 3 Page Start: S162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effectiveness and safety of 1L PEG-ASC preparation for colonoscopy in patients with inflammatory bowel diseases. Issue 9 (September 2021) Authors: Maida, M.; Morreale, G.C.; Sferrazza, S.; Sinagra, E.; Scalisi, G.; Vitello, A.; Vettori, G.; Rossi, F.; Catarella, D.; Di Bartolo, C.E.; Schillaci, D.; Raimondo, D.; Camilleri, S.; Orlando, A.; Macaluso, F.S. Journal: Digestive and liver disease Issue: Volume 53:Issue 9(2021) Page Start: 1171 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Effectiveness and safety of NER1006 versus standard bowel preparations: A meta-analysis of randomized phase-3 clinical trials. Issue 8 (August 2020) Authors: Maida, M.; Macaluso, F.S.; Sferrazza, S.; Ventimiglia, M.; Sinagra, E. Journal: Digestive and liver disease Issue: Volume 52:Issue 8(2020) Page Start: 833 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OC.02.1 SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD). (May 2022) Authors: Todeschini, A.; Contaldo, A.; Macaluso, F.S.; Facciotti, F.; Castiglione, F.; Nardone, O.M.; Spagnuolo, R.; Doldo, P.; Riguccio, G.; Conforti, F.S.; Viganò, C.; Ascolani, M.; Bodini, G.; Milla, M.; Scardino, G.; Vernero, M.; Desideri, F.; Mannino, M.; Rizzo, G.; Di Leo, A. Journal: Digestive and liver disease Issue: Volume 54(2022)Supplement 2 Page Start: S71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OC.02.3 A PROPENSITY SCORE WEIGHTED COMPARISON OF VEDOLIZUMAB, ADALIMUMAB, AND GOLIMUMAB IN PATIENTS WITH ULCERATIVE COLITIS: REAL-LIFE DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD). (1st October 2020) Authors: Macaluso, F.S.; Ventimiglia, M.; Fries, W.; Viola, A.; Cappello, M.; Scrivo, B.; Magnano, A.; Pluchino, D.; Camilleri, S.; Garufi, S.; Di Mitri, R.; Mocciaro, F.; Magrì, G.; Ferracane, C.; Citrano, M.; Graziano, F.; Bertolami, C.; Renna, S.; Orlando, R.; Rizzuto, G. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 2 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. OC.06.2: The Sicilian Network of Biological Therapy in Inflammatory Bowel Disease: Preliminary Data from a Prospective Study on Efficacy and Safety. (15th March 2017) Authors: Orlando, A.; Fries, W.; Privitera, A.; Cappello, M.; Siringo, S.; Inserra, G.; Magnano, A.; Di Mitri, R.; Belluardo, N.; Scarpulla, G.; Magrì, G.; Trovatello, A.; Carroccio, A.; Genova, S.; Calandruccio, G.; Vassallo, R.; Romano, C.; Magazzù, G.; Citrano, M.; Accomando, S. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e91 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. OC.06.4: The Addition of an Immunosuppressant is an Effective Optimization Strategy after Loss of Response to Anti-Tnf Alpha Monotherapy in Patients with Inflammatory Bowel Disease: A Two-Year Experience. (15th March 2017) Authors: Macaluso, F.S.; Sapienza, C.; Ventimiglia, M.; Renna, S.; Rizzuto, G.; Orlando, R.; Affronti, M.; Orlando, E.; Cottone, M.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OC.06.5: Mycophenolate Mofetil is a Valid Option in Patients with Inflammatory Bowel Disease Resistant to TNF-Alpha Inhibitors and Conventional Immunosuppressants. (15th March 2017) Authors: Macaluso, F.S.; Maida, M.; Renna, S.; Orlando, E.; Affronti, M.; Sapienza, C.; Dimarco, M.; Orlando, R.; Rizzuto, G.; Cottone, M.; Orlando, A. Journal: Digestive and liver disease Issue: Volume 49(2017)Supplement 2 Page Start: e92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗